Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Investigational use of 5-ALA for fluorescence-guided resection of malignant glioma
2006-002606-54Phase 3Active
- Sponsor
- ASL Salerno
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of 5-aminolevulinic acid in glioblastoma (GBM) and malignant glioma, sponsored by ASL Salerno. Primary endpoint: Residual glioma volume on early postoperative MRI. Started Jun 2006; status: active.
02
Drugs
5-aminolevulinic acid
03
Conditions
glioblastoma (GBM)malignant glioma
Beyond the preview
Go deeper on 2006-002606-54.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002606-54.